Standard
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine : Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies. / Ashina, Messoud; Vasudeva, Raghavendra; Jin, Leah; Lombard, Louise; Gray, Elizabeth; Doty, Erin G.; Yunes-Medina, Laura; Kinchen, Kraig S.; Tassorelli, Cristina.
In:
Headache, Vol. 59, No. 10, 2019, p. 1788-1801.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Ashina, M, Vasudeva, R, Jin, L, Lombard, L, Gray, E, Doty, EG, Yunes-Medina, L, Kinchen, KS & Tassorelli, C 2019, '
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies',
Headache, vol. 59, no. 10, pp. 1788-1801.
https://doi.org/10.1111/head.13636
APA
Ashina, M., Vasudeva, R., Jin, L., Lombard, L., Gray, E., Doty, E. G., Yunes-Medina, L., Kinchen, K. S., & Tassorelli, C. (2019).
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
Headache,
59(10), 1788-1801.
https://doi.org/10.1111/head.13636
Vancouver
Ashina M, Vasudeva R, Jin L, Lombard L, Gray E, Doty EG et al.
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
Headache. 2019;59(10):1788-1801.
https://doi.org/10.1111/head.13636
Author
Ashina, Messoud ; Vasudeva, Raghavendra ; Jin, Leah ; Lombard, Louise ; Gray, Elizabeth ; Doty, Erin G. ; Yunes-Medina, Laura ; Kinchen, Kraig S. ; Tassorelli, Cristina. / Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine : Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies. In: Headache. 2019 ; Vol. 59, No. 10. pp. 1788-1801.
Bibtex
@article{f9b6afaa5917427aad0507bc8aaa7f73,
title = "Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies",
keywords = "lasmiditan, migraine, onset of efficacy, onset of response, acute treatment, ditan class",
author = "Messoud Ashina and Raghavendra Vasudeva and Leah Jin and Louise Lombard and Elizabeth Gray and Doty, {Erin G.} and Laura Yunes-Medina and Kinchen, {Kraig S.} and Cristina Tassorelli",
year = "2019",
doi = "10.1111/head.13636",
language = "English",
volume = "59",
pages = "1788--1801",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "10",
}
RIS
TY - JOUR
T1 - Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine
T2 - Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies
AU - Ashina, Messoud
AU - Vasudeva, Raghavendra
AU - Jin, Leah
AU - Lombard, Louise
AU - Gray, Elizabeth
AU - Doty, Erin G.
AU - Yunes-Medina, Laura
AU - Kinchen, Kraig S.
AU - Tassorelli, Cristina
PY - 2019
Y1 - 2019
KW - lasmiditan
KW - migraine
KW - onset of efficacy
KW - onset of response
KW - acute treatment
KW - ditan class
U2 - 10.1111/head.13636
DO - 10.1111/head.13636
M3 - Journal article
C2 - 31529622
VL - 59
SP - 1788
EP - 1801
JO - Headache
JF - Headache
SN - 0017-8748
IS - 10
ER -
